Pyodermatitis-pyostomatitis vegetans: a case report and systematic review focusing on oral involvement.
Bruno Ramos ChrcanovicRoberta Rayra Martins ChavesFlávia Sirotheau Correa PontesHelder Antonio Rebelo PontesHélder Antônio Rebelo PontesRicardo Santiago GomezPublished in: Oral and maxillofacial surgery (2024)
Sixty-two publications with 77 cases of PSV and an associated IBD were included. Features that are helpful in establishing the diagnosis of PSV are snail track appearance of oral lesions, an associated IBD (which is not always symptomatic), evidence of intraepithelial clefting on microscopic examination of oral lesions, and peripheral blood eosinophilia. A gold standard for the management of PSV does not exist and high-level evidence is limited. There is no established therapeutic protocol for PSV and management primarily consists of topical and/or systemic corticosteroids, antirheumatic drugs (sulfasalazine, mesalazine), monoclonal antibody (infliximab, adalimumab) immunosuppressives (azathioprine, methotrexate), antibiotics (dapsone), or a combination of these. The risk of recurrence of oral lesions is considerable when the medication dose is decreased or fully interrupted.
Keyphrases
- systematic review
- monoclonal antibody
- peripheral blood
- rheumatoid arthritis
- ulcerative colitis
- randomized controlled trial
- epithelial mesenchymal transition
- healthcare
- high grade
- emergency department
- meta analyses
- signaling pathway
- high dose
- systemic lupus erythematosus
- juvenile idiopathic arthritis
- drug induced
- rheumatoid arthritis patients
- disease activity
- silver nanoparticles